Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/31987
Title: Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study
Authors: Shieh, P
Hughes, W
Wood, M
Beggs, A
Lawlor, M
Coats, J
Varfaj, F
Graham, R
Kuntz, N
Dowling, J
Muller-Felber, W
Bonnemann, C
Buj Bello, A
Servais, L
MacBean, V
Muntoni, F
Foley, AR
Blaschek, A
James, E
Seferian, A
Alfano, L
Duong, T
Noursalehi, M
Miller, W
Lee, J
Prasad, S
Rico, S
Keywords: gene therapy;X-linked myotubular myopathy;resamirigene bilparvovec
Issue Date: 18-Sep-2025
Publisher: SAGE Publications
Citation: Shieh, P. et al. (2025) 'Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study', Therapeutic Advances in Rare Disease, 6, pp. 1 - 12. doi: 10.1177/26330040251362885.
Abstract: What is this summary about? This summary describes the results of a research study (clinical trial) called ASPIRO that was published in the Lancet Neurology in 2023. This study looked at an investigational gene therapy called resamirigene bilparvovec (also known as AT132) as a possible treatment for children with a disease called X-linked myotubular myopathy (abbreviated as XLMTM).
Description: Availability of data and materials: Details for how researchers may request access to anonymized participant level data, trial-level data, and protocols from Astellas sponsored clinical trials can be found at https://www.clinicaltrials.astellas.com/transparency/.
URI: https://bura.brunel.ac.uk/handle/2438/31987
DOI: https://doi.org/10.1177/26330040251362885
Other Identifiers: ORCiD: Perry B. Shieh https://orcid.org/0000-0001-7145-7663
ORCiD: Marie Wood https://orcid.org/0009-0000-1665-3004
ORCiD: Michael W. Lawlor https://orcid.org/0000-0003-0731-3950
ORCiD: Victoria MacBean https://orcid.org/0000-0003-0268-2693
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s), 2025. Rights and permissions: Creative Commons License (CC BY 4.0). This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).1.24 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons